BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/11/2022 12:39:21 AM | Browse: 287 | Download: 812
 |
Received |
|
2021-09-16 17:59 |
|
Peer-Review Started |
|
2021-09-16 18:01 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-18 17:06 |
|
Revised |
|
2021-12-03 08:34 |
|
Second Decision |
|
2022-01-21 05:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-01-23 03:44 |
|
Articles in Press |
|
2022-01-23 03:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-02-23 07:29 |
|
Publish the Manuscript Online |
|
2022-03-11 00:39 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shouki Bazarbashi, Abdulrahman Alghabban, Mohamed Aseafan, Ali H Aljubran, Ahmed Alzahrani and Tusneem AM Elhassan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shouki Bazarbashi, MBBS, Professor, Oncology Center, King Faisal Specialist Hospital & Research Center, Alzahrawi street, Riyadh 11211, Riyadh, Saudi Arabia. bazarbashi@kfshrc.edu.sa |
| Key Words |
Colorectal cancer; Peritoneal carcinomatosis; Triplet chemotherapy; Survival; Prognostic factors; Metastasectomy |
| Core Tip |
The established poor prognostic indicator of peritoneal metastasis in metastatic colorectal cancer (CRC) has been in patients treated with single agent or doublet chemotherapy. In our study, we retrospectively demonstrated that in patients treated with triplet chemotherapy in the first-line setting, the significance of peritoneal metastasis as a poor prognostic factor was lost. This might suggest a beneficial therapeutic effect of triplet chemotherapy in the first-line setting in patients with metastatic CRC and peritoneal metastasis. |
| Publish Date |
2022-03-11 00:39 |
| Citation |
Bazarbashi S, Alghabban A, Aseafan M, Aljubran AH, Alzahrani A, Elhassan TA. Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy. World J Clin Cases 2022; 10(8): 2429-2438 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i8/2429.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i8.2429 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
